Sloan S - Search Results

1

Impairment of esophageal emptying with hiatal hernia.

Sloan S, Kahrilas PJ. Sloan S, et al. Gastroenterology. 1991 Mar;100(3):596-605. doi: 10.1016/0016-5085(91)80003-r. Gastroenterology. 1991. PMID: 1993483

2

Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease.

Kahrilas PJ, Miner P, Johanson J, Mao L, Jokubaitis L, Sloan S. Kahrilas PJ, et al. Among authors: sloan s. Dig Dis Sci. 2005 Nov;50(11):2009-18. doi: 10.1007/s10620-005-3000-3. Dig Dis Sci. 2005. PMID: 16240208 Clinical Trial.

3

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors.

Gerson LB, Triadafilopoulos G, Sahbaie P, Young W, Sloan S, Robinson M, Miner PB Jr, Gardner JD. Gerson LB, et al. Among authors: sloan s. BMC Gastroenterol. 2008 May 23;8:15. doi: 10.1186/1471-230X-8-15. BMC Gastroenterol. 2008. PMID: 18498663 Free PMC article.

4

Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease.

Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Jones MP, et al. Among authors: sloan ss. Am J Gastroenterol. 2001 Jun;96(6):1711-7. doi: 10.1111/j.1572-0241.2001.03926.x. Am J Gastroenterol. 2001. PMID: 11419819

5

Impaired egress rather than increased access: an important independent predictor of erosive oesophagitis.

Jones MP, Sloan SS, Jovanovic B, Kahrilas PJ. Jones MP, et al. Among authors: sloan ss. Neurogastroenterol Motil. 2002 Dec;14(6):625-31. doi: 10.1046/j.1365-2982.2002.00362.x. Neurogastroenterol Motil. 2002. PMID: 12464084

6

Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both?

Sloan S, Rademaker AW, Kahrilas PJ. Sloan S, et al. Ann Intern Med. 1992 Dec 15;117(12):977-82. doi: 10.7326/0003-4819-117-12-977. Ann Intern Med. 1992. PMID: 1443984

7

The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.

Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D. Farup C, et al. Among authors: sloan s. Arch Intern Med. 2001 Jan 8;161(1):45-52. doi: 10.1001/archinte.161.1.45. Arch Intern Med. 2001. PMID: 11146697

8

Exploring the physiologic role of human gastroesophageal reflux by analyzing time-series data from 24-h gastric and esophageal pH recordings.

Lu L, Mu JC, Sloan S, Miner PB, Gardner JD. Lu L, et al. Among authors: sloan s. Physiol Rep. 2014 Jul 16;2(7):e12051. doi: 10.14814/phy2.12051. Physiol Rep. 2014. PMID: 25347850 Free PMC article.

9

Maintenance of efficacy and safety of rabeprazole in children with endoscopically proven GERD.

Haddad I, Kierkus J, Tron E, Ulmer A, Hu P, Silber S, Sloan S, Leitz GJ. Haddad I, et al. Among authors: sloan s. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):510-7. doi: 10.1097/MPG.0000000000000229. J Pediatr Gastroenterol Nutr. 2014. PMID: 24164904 Clinical Trial.

10

Efficacy and safety of rabeprazole in children (1-11 years) with gastroesophageal reflux disease.

Haddad I, Kierkus J, Tron E, Ulmer A, Hu P, Sloan S, Silber S, Leitz G. Haddad I, et al. Among authors: sloan s. J Pediatr Gastroenterol Nutr. 2013 Dec;57(6):798-807. doi: 10.1097/MPG.0b013e3182a4e718. J Pediatr Gastroenterol Nutr. 2013. PMID: 23863328 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results